Cellebrite Di Stock Short Ratio
| CLBT Stock | USD 19.72 0.46 2.28% |
Cellebrite DI fundamentals help investors to digest information that contributes to Cellebrite's financial success or failures. It also enables traders to predict the movement of Cellebrite Stock. The fundamental analysis module provides a way to measure Cellebrite's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cellebrite stock.
Cellebrite | Short Ratio |
Cellebrite DI Company Short Ratio Analysis
Cellebrite's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Cellebrite Short Ratio | 1.32 X |
Most of Cellebrite's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cellebrite DI is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cellebrite Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Cellebrite is extremely important. It helps to project a fair market value of Cellebrite Stock properly, considering its historical fundamentals such as Short Ratio. Since Cellebrite's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cellebrite's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cellebrite's interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Cellebrite Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Cellebrite DI has a Short Ratio of 1.32 times. This is 72.78% lower than that of the Software sector and significantly higher than that of the Information Technology industry. The short ratio for all United States stocks is 67.0% higher than that of the company.
Cellebrite Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cellebrite's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cellebrite could also be used in its relative valuation, which is a method of valuing Cellebrite by comparing valuation metrics of similar companies.Cellebrite is currently under evaluation in short ratio category among its peers.
Cellebrite ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cellebrite's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cellebrite's managers, analysts, and investors.Environmental | Governance | Social |
Cellebrite Institutional Holders
Institutional Holdings refers to the ownership stake in Cellebrite that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Cellebrite's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cellebrite's value.| Shares | Pembroke Management Ltd | 2024-09-30 | 1.9 M | Ashford Capital Management Inc | 2024-06-30 | 1.9 M | Blackrock Inc | 2024-06-30 | 1.9 M | Crescent Park Management, L.p. | 2024-09-30 | 1.7 M | Two Sigma Investments Llc | 2024-09-30 | 1.6 M | Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Ltd | 2024-09-30 | 1.5 M | Renaissance Technologies Corp | 2024-09-30 | 1.5 M | Principal Financial Group Inc | 2024-09-30 | 1.4 M | Goldman Sachs Group Inc | 2024-06-30 | 1.3 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 14 M | True Wind Capital Management, L.p. | 2024-09-30 | 11.7 M |
Cellebrite Fundamentals
| Return On Equity | -1.88 | ||||
| Return On Asset | 0.0635 | ||||
| Profit Margin | (0.82) % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 3.88 B | ||||
| Shares Outstanding | 214.84 M | ||||
| Shares Owned By Insiders | 46.79 % | ||||
| Shares Owned By Institutions | 52.99 % | ||||
| Number Of Shares Shorted | 1.51 M | ||||
| Price To Earning | 82.18 X | ||||
| Price To Book | 14.20 X | ||||
| Price To Sales | 11.00 X | ||||
| Revenue | 325.11 M | ||||
| Gross Profit | 219.91 M | ||||
| EBITDA | (64.8 M) | ||||
| Net Income | (81.1 M) | ||||
| Cash And Equivalents | 142.51 M | ||||
| Cash Per Share | 0.75 X | ||||
| Total Debt | 14.13 M | ||||
| Current Ratio | 1.35 X | ||||
| Book Value Per Share | 1.43 X | ||||
| Cash Flow From Operations | 102.06 M | ||||
| Short Ratio | 1.32 X | ||||
| Earnings Per Share | (1.58) X | ||||
| Price To Earnings To Growth | 13.39 X | ||||
| Target Price | 22.43 | ||||
| Number Of Employees | 1.01 K | ||||
| Beta | 1.5 | ||||
| Market Capitalization | 4.24 B | ||||
| Total Asset | 540.4 M | ||||
| Retained Earnings | 118.14 M | ||||
| Working Capital | 168.26 M | ||||
| Net Asset | 540.4 M |
About Cellebrite Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cellebrite DI's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cellebrite using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cellebrite DI based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cellebrite Stock Analysis
When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.